# Harmonized AS/MQ Efficacy Study - Thailand

> **NCT02052323** · PHASE4 · COMPLETED · sponsor: **Armed Forces Research Institute of Medical Sciences, Thailand** · enrollment: 48 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artesunate/mefloquine (AS/MQ)

## Key facts

- **NCT ID:** NCT02052323
- **Lead sponsor:** Armed Forces Research Institute of Medical Sciences, Thailand
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2016-01-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02052323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02052323, "Harmonized AS/MQ Efficacy Study - Thailand". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02052323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*